In terms of the Letter of Offer dated November 1, 2021 and in accordance with the Basis of Allotment finalized in consultation with BSE Limited (Designated Stock Exchange), the Lead Manager to the Issue and the Registrar to the Issue, the Rights Issue Committee of Directors of the Company, pursuant to the delegation of the authority to the Rights Issue Committee by the Board of Directors at their meeting held on May 13, 2021, has, at its meeting held on today, i.e., December 4, 2021, approved the allotment of 96,20,463 Rights Equity Shares of face value of ?10 each at a price of ?300 per Rights Equity Share including a share premium of ?290 per Rights Equity Share.